Form 8-K - Current report:
SEC Accession No. 0001520138-24-000254
Filing Date
2024-08-01
Accepted
2024-08-01 16:41:49
Documents
15
Period of Report
2024-07-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20240729_8k.htm   iXBRL 8-K 34634
2 EXHIBIT 3.1 bivi-20240729_8kex3z1.htm EX-3.1 472
6 GRAPHIC image001.jpg GRAPHIC 151869
  Complete submission text file 0001520138-24-000254.txt   420298

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20240729.xsd EX-101.SCH 3027
4 XBRL LABEL FILE bivi-20240729_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bivi-20240729_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240729_8k_htm.xml XML 3687
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 241167419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)